- Home
- WRAP vs SAVA Comparison
WRAP vs SAVA Comparison
Compare WRAP & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- SAVA
- Stock Information
- Founded
- WRAP 2016
- SAVA 1998
- Country
- WRAP United States
- SAVA United States
- Employees
- WRAP N/A
- SAVA N/A
- Industry
- WRAP Ordnance And Accessories
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- WRAP Industrials
- SAVA Health Care
- Exchange
- WRAP Nasdaq
- SAVA Nasdaq
- Market Cap
- WRAP 74.7M
- SAVA 70.5M
- IPO Year
- WRAP N/A
- SAVA N/A
- Fundamental
- Price
- WRAP $1.41
- SAVA $2.10
- Analyst Decision
- WRAP
- SAVA Buy
- Analyst Count
- WRAP 0
- SAVA 3
- Target Price
- WRAP N/A
- SAVA $54.50
- AVG Volume (30 Days)
- WRAP 124.8K
- SAVA 1.3M
- Earning Date
- WRAP 05-15-2025
- SAVA 05-08-2025
- Dividend Yield
- WRAP N/A
- SAVA N/A
- EPS Growth
- WRAP N/A
- SAVA N/A
- EPS
- WRAP N/A
- SAVA N/A
- Revenue
- WRAP $3,796,000.00
- SAVA N/A
- Revenue This Year
- WRAP N/A
- SAVA N/A
- Revenue Next Year
- WRAP N/A
- SAVA N/A
- P/E Ratio
- WRAP N/A
- SAVA N/A
- Revenue Growth
- WRAP N/A
- SAVA N/A
- 52 Week Low
- WRAP $1.21
- SAVA $1.15
- 52 Week High
- WRAP $2.58
- SAVA $42.20
- Technical
- Relative Strength Index (RSI)
- WRAP 44.91
- SAVA 58.24
- Support Level
- WRAP $1.30
- SAVA $1.96
- Resistance Level
- WRAP $1.50
- SAVA $2.22
- Average True Range (ATR)
- WRAP 0.09
- SAVA 0.15
- MACD
- WRAP 0.01
- SAVA 0.00
- Stochastic Oscillator
- WRAP 48.21
- SAVA 51.09
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.